Table 3.
Prescription medications at discharge among hospitalized acute myocardial infarction patients in Göteborg, Sweden and Minneapolis–St. Paul, USA
| Men |
Women |
|||||
|---|---|---|---|---|---|---|
| MSP (n = 355) | GB (n = 235) | P-value | MSP (n = 424) | GB (n = 249) | P-value | |
| Medication (%) | ||||||
| Aspirin | 80.6 | 86.0 | 0.14 | 80.7 | 87.1 | 0.03 |
| Anti-platelet agents | 42.5 | 11.9 | <0.0001 | 42.0 | 12.9 | <0.0001 |
| β-Blockers | 73.8 | 85.1 | 0.01 | 74.5 | 86.7 | 0.0002 |
| Calcium-channel blockers | 22.0 | 14.5 | 0.05 | 21.5 | 16.9 | 0.15 |
| Nitrates | 66.5 | 47.2 | <0.0001 | 67.5 | 45.8 | <0.0001 |
| Digitalis | 15.5 | 12.3 | 0.35 | 15.1 | 16.5 | 0.64 |
| Diuretics | 45.1 | 62.6 | 0.002 | 50.9 | 67.9 | <0.0001 |
| ACE-inhibitors | 51.3 | 41.7 | 0.04 | 53.8 | 32.1 | <0.0001 |
| Lipid lowering agents | 51.8 | 35.9 | 0.001 | 44.8 | 23.7 | <0.0001 |